Flutivate (Cutivat) Smyrsli 0,005 % Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

flutivate (cutivat) smyrsli 0,005 %

glaxosmithkline pharma a/s - fluticasonum própíónat - smyrsli - 0,005 %

Imigran Nefúði, lausn 20 mg/skammt Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

imigran nefúði, lausn 20 mg/skammt

glaxosmithkline pharma a/s - sumatriptanum inn - nefúði, lausn - 20 mg/skammt

Imigran Radis Filmuhúðuð tafla 100 mg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

imigran radis filmuhúðuð tafla 100 mg

glaxosmithkline pharma a/s - sumatriptanum súkkínat - filmuhúðuð tafla - 100 mg

Imigran Radis Filmuhúðuð tafla 50 mg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

imigran radis filmuhúðuð tafla 50 mg

glaxosmithkline pharma a/s - sumatriptanum súkkínat - filmuhúðuð tafla - 50 mg

Varilrix Stungulyfsstofn og leysir, lausn 2.000 PFU bóluefni Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

varilrix stungulyfsstofn og leysir, lausn 2.000 pfu bóluefni

glaxosmithkline pharma a/s - varicella-zoster virus - stungulyfsstofn og leysir, lausn - 2.000 pfu bóluefni

Ventoline Lausn í eimgjafa 1 mg/ml Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

ventoline lausn í eimgjafa 1 mg/ml

glaxosmithkline pharma a/s - salbutamolum súlfat - lausn í eimgjafa - 1 mg/ml

Zovirax (Zovir) Innrennslisstofn, lausn 500 mg/hgl. Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

zovirax (zovir) innrennslisstofn, lausn 500 mg/hgl.

glaxosmithkline pharma a/s - aciclovirum inn - innrennslisstofn, lausn - 500 mg/hgl.

Zovirax (Zovir) Mixtúra, dreifa 80 mg/ml Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

zovirax (zovir) mixtúra, dreifa 80 mg/ml

glaxosmithkline pharma a/s - aciclovirum inn - mixtúra, dreifa - 80 mg/ml

Arexvy Unión Europea - islandés - EMA (European Medicines Agency)

arexvy

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - sýkingar af völdum sýklalyfja - bóluefni - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. notkun þetta bóluefni ætti að vera í samræmi við opinbera tillögur.

Bexsero Unión Europea - islandés - EMA (European Medicines Agency)

bexsero

gsk vaccines s.r.l. - ytri himnu frá neisseria meningitidis hópur b (álag nýja-sjáland 98/254), skal læknir hafa neisseria meningitidis hópur b fhbp samruna prótín, skal læknir hafa neisseria meningitidis hópur b nada prótín, skal læknir hafa neisseria meningitidis hópur b nhba samruna prótín - meningitis, meningococcal - meningókokka bóluefni - virkt ónæmisaðgerðir gegn innrásarsjúkdómum af völdum neisseria meningitidis serogroup-b stofnanna.